Cargando…

Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK

BACKGROUND: To use routinely collected data to develop a five-year cardiovascular disease (CVD) risk prediction model for Chinese adults with type 2 diabetes with validation of its performance in a population of European ancestry. METHODS: People with incident type 2 diabetes and no history of CVD a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Cheng, Read, Stephanie, Wu, Honghan, Lu, Shan, Zhang, Xin, Wild, Sarah H., Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336685/
https://www.ncbi.nlm.nih.gov/pubmed/36051323
http://dx.doi.org/10.5334/gh.1131
_version_ 1784759590693371904
author Wan, Cheng
Read, Stephanie
Wu, Honghan
Lu, Shan
Zhang, Xin
Wild, Sarah H.
Liu, Yun
author_facet Wan, Cheng
Read, Stephanie
Wu, Honghan
Lu, Shan
Zhang, Xin
Wild, Sarah H.
Liu, Yun
author_sort Wan, Cheng
collection PubMed
description BACKGROUND: To use routinely collected data to develop a five-year cardiovascular disease (CVD) risk prediction model for Chinese adults with type 2 diabetes with validation of its performance in a population of European ancestry. METHODS: People with incident type 2 diabetes and no history of CVD at diagnosis of diabetes between 2008 and 2017 were included in derivation and validation cohorts. The derivation cohort was identified from a pseudonymized research extract of data from the First Affiliated Hospital of Nanjing Medical University (NMU). Five-year risk of CVD was estimated using basic and extended Cox proportional hazards regression models including 6 and 11 predictors respectively. The risk prediction models were internally validated and externally validated in a Scottish population–based cohort with CVD events identified from linked hospital records. Discrimination and calibration were assessed using Harrell’s C-statistic and calibration plots, respectively. RESULTS: Mean age of the derivation and validation cohorts were 58.4 and 59.2 years, respectively, with 53.5% and 56.9% men. During a median follow-up time of 4.75 [2.67, 7.42] years, 18,827 (22.25%) of the 84,630 people in the NMU-Diabetes cohort and 8,763 (7.31%) of the Scottish cohort of 119,891 people developed CVD. The extended model had a C-statistic of 0.723 [0.721–0.724] in internal validation and 0.716 [0.713–0.719] in external validation. CONCLUSIONS: It is possible to generate a risk prediction model with moderate discriminative power in internal and external validation derived from routinely collected Chinese hospital data. The proposed risk score could be used to improve CVD prevention in people with diabetes.
format Online
Article
Text
id pubmed-9336685
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ubiquity Press
record_format MEDLINE/PubMed
spelling pubmed-93366852022-08-31 Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK Wan, Cheng Read, Stephanie Wu, Honghan Lu, Shan Zhang, Xin Wild, Sarah H. Liu, Yun Glob Heart Original Research BACKGROUND: To use routinely collected data to develop a five-year cardiovascular disease (CVD) risk prediction model for Chinese adults with type 2 diabetes with validation of its performance in a population of European ancestry. METHODS: People with incident type 2 diabetes and no history of CVD at diagnosis of diabetes between 2008 and 2017 were included in derivation and validation cohorts. The derivation cohort was identified from a pseudonymized research extract of data from the First Affiliated Hospital of Nanjing Medical University (NMU). Five-year risk of CVD was estimated using basic and extended Cox proportional hazards regression models including 6 and 11 predictors respectively. The risk prediction models were internally validated and externally validated in a Scottish population–based cohort with CVD events identified from linked hospital records. Discrimination and calibration were assessed using Harrell’s C-statistic and calibration plots, respectively. RESULTS: Mean age of the derivation and validation cohorts were 58.4 and 59.2 years, respectively, with 53.5% and 56.9% men. During a median follow-up time of 4.75 [2.67, 7.42] years, 18,827 (22.25%) of the 84,630 people in the NMU-Diabetes cohort and 8,763 (7.31%) of the Scottish cohort of 119,891 people developed CVD. The extended model had a C-statistic of 0.723 [0.721–0.724] in internal validation and 0.716 [0.713–0.719] in external validation. CONCLUSIONS: It is possible to generate a risk prediction model with moderate discriminative power in internal and external validation derived from routinely collected Chinese hospital data. The proposed risk score could be used to improve CVD prevention in people with diabetes. Ubiquity Press 2022-07-28 /pmc/articles/PMC9336685/ /pubmed/36051323 http://dx.doi.org/10.5334/gh.1131 Text en Copyright: © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Wan, Cheng
Read, Stephanie
Wu, Honghan
Lu, Shan
Zhang, Xin
Wild, Sarah H.
Liu, Yun
Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK
title Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK
title_full Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK
title_fullStr Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK
title_full_unstemmed Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK
title_short Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK
title_sort prediction of five-year cardiovascular disease risk in people with type 2 diabetes mellitus: derivation in nanjing, china and external validation in scotland, uk
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336685/
https://www.ncbi.nlm.nih.gov/pubmed/36051323
http://dx.doi.org/10.5334/gh.1131
work_keys_str_mv AT wancheng predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk
AT readstephanie predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk
AT wuhonghan predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk
AT lushan predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk
AT zhangxin predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk
AT wildsarahh predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk
AT liuyun predictionoffiveyearcardiovasculardiseaseriskinpeoplewithtype2diabetesmellitusderivationinnanjingchinaandexternalvalidationinscotlanduk